Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT04023552
PHASE3

Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With CVD

Sponsor: Novartis Pharmaceuticals

View on ClinicalTrials.gov

Summary

This is a pivotal phase 3 study designed to support an indication for the reduction of cardiovascular risk in patients with established CVD and elevated Lp(a)

Official title: A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With Established Cardiovascular Disease

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

8323

Start Date

2019-12-12

Completion Date

2026-07-16

Last Updated

2026-08-28

Healthy Volunteers

No

Interventions

DRUG

TQJ230

TQJ230 80 mg injected monthly administered subcutaneously

DRUG

Placebo

Placebo to match TQJ230 prefilled syringe to be injected subcutaneously

Locations (902)

SEC Clinical Research LLC

Andalusia, Alabama, United States

Grandview Med Group Research LLC

Birmingham, Alabama, United States

Novartis Investigative Site

Birmingham, Alabama, United States

Heart Center Research Llc

Huntsville, Alabama, United States

Novartis Investigative Site

Huntsville, Alabama, United States

Mobile Heart Specialists

Mobile, Alabama, United States

Novartis Investigative Site

Mobile, Alabama, United States

Novartis Investigative Site

Cottonwood, Arizona, United States

Mercy Gilbert Medical Center

Gilbert, Arizona, United States

Clinical Research Inst of Arizona

Sun City West, Arizona, United States

Novartis Investigative Site

Sun City West, Arizona, United States

Eclipse Clinical Research

Tucson, Arizona, United States

Novartis Investigative Site

Tucson, Arizona, United States

Cardiology and Medicine Clinic PA

Little Rock, Arkansas, United States

Novartis Investigative Site

Little Rock, Arkansas, United States

Cardiovascular Res Found

Beverly Hills, California, United States

National Heart Institute

Beverly Hills, California, United States

Novartis Investigative Site

Beverly Hills, California, United States

Flourish Clinical Resrch Covin

Covina, California, United States

Novartis Investigative Site

Covina, California, United States

Diabetes Lipid Management Center

Huntington Beach, California, United States

Novartis Investigative Site

Huntington Beach, California, United States

University of Calif Irvine Med Cntr

Irvine, California, United States

Novartis Investigative Site

La Jolla, California, United States

Memorial Care Health System

Long Beach, California, United States

Novartis Investigative Site

Long Beach, California, United States

Keck Medical Center USC

Los Angeles, California, United States

Novartis Investigative Site

Los Angeles, California, United States

Novartis Investigative Site

Los Angeles, California, United States

Novartis Investigative Site

Northridge, California, United States

Valley Clinical Trials

Northridge, California, United States

Novartis Investigative Site

Orange, California, United States

Stanford University Medical Center

Palo Alto, California, United States

University of California San Diego

San Diego, California, United States

UCSF

San Francisco, California, United States

Novartis Investigative Site

San Francisco, California, United States

Helping Hands Medical Associates INC

Santa Ana, California, United States

Novartis Investigative Site

Santa Ana, California, United States

Novartis Investigative Site

Stanford, California, United States

Manshadi Heart Institute

Stockton, California, United States

Novartis Investigative Site

Stockton, California, United States

Interv Cardiology Med Grp

West Hills, California, United States

Novartis Investigative Site

West Hills, California, United States

Novartis Investigative Site

Aurora, Colorado, United States

Univ Of Color Anschutz Med Center

Aurora, Colorado, United States

Bridgeport Hospital

Bridgeport, Connecticut, United States

Novartis Investigative Site

Bridgeport, Connecticut, United States

Novartis Investigative Site

Hartford, Connecticut, United States

Hartford Hospital

Hartford, Connecticut, United States

Chase Medical Research LLC

Waterbury, Connecticut, United States

Novartis Investigative Site

Waterbury, Connecticut, United States

Excel Medical Clinical Trials LLC

Boca Raton, Florida, United States

Novartis Investigative Site

Boca Raton, Florida, United States

Cardiovascular and Vein Center of Florida

Bradenton, Florida, United States

Novartis Investigative Site

Bradenton, Florida, United States

Bay Area Cardiology Assoc

Brandon, Florida, United States

Novartis Investigative Site

Brandon, Florida, United States

Novartis Investigative Site

Fort Lauderdale, Florida, United States

CV Consultants of South Broward

Hollywood, Florida, United States

Novartis Investigative Site

Jacksonville, Florida, United States

Westside Center for Clinical Research

Jacksonville, Florida, United States

East Coast Institute for Research

Jacksonville, Florida, United States

Jacksonville Center for Clinical Research

Jacksonville, Florida, United States

Novartis Investigative Site

Jacksonville, Florida, United States

Infinite Clinical Research

Miami, Florida, United States

Novartis Investigative Site

Miami, Florida, United States

Advanced Research for Health Improvement LLC

Naples, Florida, United States

Novartis Investigative Site

Naples, Florida, United States

Southwest Florida Research

Naples, Florida, United States

Novartis Investigative Site

Port Charlotte, Florida, United States

Peace River Cardiovascular Center

Port Charlotte, Florida, United States

Novartis Investigative Site

Port Orange, Florida, United States

Progressive Medical Research

Port Orange, Florida, United States

East Coast Inst for Research LLC

Saint Augustine, Florida, United States

Novartis Investigative Site

Saint Augustine, Florida, United States

Cardiology Partners Clinical Research Institute

Wellington, Florida, United States

Novartis Investigative Site

Wellington, Florida, United States

Novartis Investigative Site

Atlanta, Georgia, United States

Grady Health System

Atlanta, Georgia, United States

Novartis Investigative Site

Atlanta, Georgia, United States

Piedmont Heart Institute

Atlanta, Georgia, United States

Emory University

Atlanta, Georgia, United States

Novartis Investigative Site

Atlanta, Georgia, United States

Novartis Investigative Site

Dunwoody, Georgia, United States

Alta Pharmaceutical Research Center

Peachtree Corners, Georgia, United States

Cardiovascular Consultants of S GA

Thomasville, Georgia, United States

Novartis Investigative Site

Thomasville, Georgia, United States

Rush University Medical Center

Chicago, Illinois, United States

Advocate Lutheran General Childrens Hospital

Park Ridge, Illinois, United States

Novartis Investigative Site

Park Ridge, Illinois, United States

Novartis Investigative Site

Indianapolis, Indiana, United States

Krannert Institute of Cardiology

Indianapolis, Indiana, United States

Novartis Investigative Site

Iowa City, Iowa, United States

Uni Of Iowa Hospitals And Clinics

Iowa City, Iowa, United States

Novartis Investigative Site

Kansas City, Kansas, United States

University of Kansas Hospital

Kansas City, Kansas, United States

Cotton O Neil Clinical Res Center

Topeka, Kansas, United States

Novartis Investigative Site

Topeka, Kansas, United States

Christus Health Central Louisiana

Alexandria, Louisiana, United States

Novartis Investigative Site

Alexandria, Louisiana, United States

And 802 more locations on ClinicalTrials.gov